Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
AN OPEN-LABEL, MULTICENTER, PHASE I TRIAL EVALUATING THE SAFETY AND PHARMACOKINETICS OF ESCALATING DOSES OF BTCT4465A IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.